Gene-therapy trials must proceed with caution

Nature. 2016 Jun 30;534(7609):590. doi: 10.1038/534590a.
No abstract available

Publication types

  • Editorial
  • Historical Article

MeSH terms

  • Adolescent
  • Animals
  • CRISPR-Cas Systems / genetics
  • Clinical Trials as Topic* / legislation & jurisprudence
  • Genetic Therapy / adverse effects*
  • Genetic Therapy / history
  • Genetic Therapy / trends*
  • Genetic Vectors / adverse effects
  • Genetic Vectors / genetics
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Male
  • Mice
  • Ornithine Carbamoyltransferase Deficiency Disease / genetics*
  • Ornithine Carbamoyltransferase Deficiency Disease / therapy*
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence